Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Matthew J. Maurer et al.|Circulation|2016Cited by 2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Heart Journal|2021Cited by 1.1k
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPhilippe Charron, Luigi Tavazzi, Michael Arad et al.|European Heart Journal|2010Cited by 485
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trialsTullio Palmerini, Gregg W. Stone, Claudio Rapezzi et al.|The Lancet|2015Cited by 394
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving mythsEsther González-López, Pablo García‐Pavía, Christian Gagliardi et al.|European Heart Journal|2017Cited by 373